tm logo
PDMO
Live/Registered
REGISTERED

on 29 Nov 2022

Last Applicant/ Owned by

Dudley, Cramlington

Northumberland

NE237QG

Serial Number

90406176 filed on 23rd Dec 2020

Registration Number

6909412 registered on 29th Nov 2022

in the Principal Register

Correspondent Address

Sarah Anne Keefe

WOMBLE BOND DICKINSON (US) LLP

P.O. BOX 7037

ATLANTA, GA 30357-0037

Filing Basis

No Filing Basis

Disclaimer

NO DATA

PDMO

Pharmaceuticals, namely, psychotropics, antihelmintics, anti-infectives, lipid lowering agents, inducers of erections, induction agents, neuromuscular blocking agents, sedatives, anti-cancer medication, anti-inflammatories, anti-fungals, anti-bacterials, anti-spasmodics, appetite stimulants, bronchodilators, appetite suppressants, anti-convulsives, neuroprotective drugs, anti-anxiety medication, aRead More

Classification Information


Class [001]
Chemical Products


Active chemical ingredients for use in the manufacture of pharmaceuticals for treating diabetes, ear, nose and throat disorders, epilepsy, genetic disorders, hematological disorders, hormonal disorders, infectious diseases, lymphoma, metabolic disorders, mouth and dental disorders, musculoskeletal disorder, non-malignant disorder, nutritional disorders, pain, rare ophthalmological diseases, rare cancers, rare infectious diseases, rare genetic diseases, rare respiratory diseases, rare central nervous system diseases, rare gastrointestinal diseases, rare immunological diseases, rare cardiovascular diseases, rare dermatological diseases, rare urinary system and sex hormone diseases, rare womens health diseases, rare ear, nose, and throat diseases, animal health disorders, cardiovascular diseases and disorders, central nervous system disorders, dermatologic disorders, endocrine system disorders, gastrointestinal diseases, genito urinary system and sex hormone imbalances, male health disorders, women's health disorders, mental health disorders, musculoskeletal disorders, renal disorders, cancer, ophthalmic disorders, renal diseases, respiratory diseases, trauma and injury

Class [005]
Pharmaceutical Products


Pharmaceuticals, namely, psychotropics, antihelmintics, anti-infectives, lipid lowering agents, inducers of erections, induction agents, neuromuscular blocking agents, sedatives, anti-cancer medication, anti-inflammatories, anti-fungals, anti-bacterials, anti-spasmodics, appetite stimulants, bronchodilators, appetite suppressants, anti-convulsives, neuroprotective drugs, anti-anxiety medication, anti-depressants, anti-ischemics, anti-psychotics; pharmaceutical preparations for treating diabetes, ear, nose and throat disorders, epilepsy, genetic disorders, hematological disorders, hormonal disorders, infectious diseases, lymphoma, metabolic disorders, mouth and dental disorders, musculoskeletal disorder, non-malignant disorder, nutritional disorders, pain, rare ophthalmological diseases, rare cancers, rare infectious diseases, rare genetic diseases, rare respiratory diseases, rare central nervous system diseases, rare gastrointestinal diseases, rare immunological diseases, rare cardiovascular diseases, rare dermatological diseases, rare urinary system and sex hormone diseases, rare womens health diseases, and rare ear, nose, and throat diseases; Pharmaceuticals, namely, pharmaceutical preparations and substances for the treatment of viral, infectious, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders for medical or veterinary purposes; vaccines; medicine for treating diabetes, ear, nose and throat disorders, epilepsy, genetic disorders, hematological disorders, hormonal disorders, infectious diseases, lymphoma, metabolic disorders, mouth and dental disorders, musculoskeletal disorder, non-malignant disorder, nutritional disorders, pain, rare ophthalmological diseases, rare cancers, rare infectious diseases, rare genetic diseases, rare respiratory diseases, rare central nervous system diseases, rare gastrointestinal diseases, rare immunological diseases, rare cardiovascular diseases, rare dermatological diseases, rare urinary system and sex hormone diseases, rare womens health diseases, and rare ear, nose, and throat diseases; chemical preparations for use in the pharmaceutical industry, namely for treating diabetes, ear, nose and throat disorders, epilepsy, genetic disorders, hematological disorders, hormonal disorders, infectious diseases, lymphoma, metabolic disorders, mouth and dental disorders, musculoskeletal disorder, non-malignant disorder, nutritional disorders, pain, rare ophthalmological diseases, rare cancers, rare infectious diseases, rare genetic diseases, rare respiratory diseases, rare central nervous system diseases, rare gastrointestinal diseases, rare immunological diseases, rare cardiovascular diseases, rare dermatological diseases, rare urinary system and sex hormone diseases, rare womens health diseases, rare ear, nose, and throat diseases, animal health disorders, cardiovascular diseases and disorders, central nervous system disorders, dermatologic disorders, endocrine system disorders, gastrointestinal diseases, genito urinary system and sex hormone imbalances, male health disorders, women's health disorders, mental health disorders, musculoskeletal disorders, renal disorders, cancer, ophthalmic disorders, renal diseases, respiratory diseases, trauma and injury

Class [040]
Treatment & Processing of Materials Services


Custom manufacture of pharmaceuticals; processing of pharmaceuticals, namely treatment in the nature of chemical processing of chemical, biochemical and pharmaceutical products for third parties; custom manufacturing services in the nature of processing of pharmaceutical preparations; processing of pharmaceutical preparations, assembly of products for others, namely, processing of pharmaceuticals, medicines, and biological preparations to the order and specification of others; treatment in the nature of chemical processing of chemical, biochemical and pharmaceutical products for third parties; treatment of materials, namely, pharmaceutical, biologic, and chemical products and their components used in the manufacture of pharmaceuticals, biotherapeutic products, and biopharmaceuticals; treatment and destruction of pharmaceutical waste; information, advice and consultancy services in relation to the aforesaid services

Class [042]
Computer & Software Services & Scientific Services


Pharmaceutical research services; pharmaceutical drug development services; pharmaceutical design services, namely, shaping and designing pills; testing of pharmaceuticals; conducting clinical trials for others relating to pharmaceuticals and chemicals; pharmaceutical analysis, namely, chemical composition analysis, testing, analysis, and evaluation of pharmaceuticals to determine conformity with certification standards; pharmaceutical laboratory research services relating to pharmaceuticals; pharmaceutical product evaluation; inspection of pharmaceuticals; biological research services; quality control and authentication services for others in the field of pharmaceuticals; information, advice and consultancy services in relation to the aforesaid services

Mark Details


Serial Number

No 90406176

Mark Type

No Service Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
29th Nov 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
29th Nov 2022REGISTERED-PRINCIPAL REGISTER
13th Sep 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
13th Sep 2022PUBLISHED FOR OPPOSITION
24th Aug 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05th Aug 2022LAW OFFICE PUBLICATION REVIEW COMPLETED
02th Aug 2022APPROVED FOR PUB - PRINCIPAL REGISTER
02th Aug 2022EXAMINER'S AMENDMENT ENTERED
02th Aug 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02th Aug 2022EXAMINERS AMENDMENT E-MAILED